2013
DOI: 10.1161/hypertensionaha.113.01184
|View full text |Cite
|
Sign up to set email alerts
|

Unexpected Cardiac Hypertrophy by Epidermal Growth Factor Receptor Silencing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…EGF–receptor transactivation and dysregulation is involved in myocardial hypertrophy and contraction ( Eguchi et al, 2013 ; Xu et al, 2014 ). In an animal model, EGF–receptor phosphorylation led to tyrosine phosphorylation of cardiac Na(+) and L-type Ca(2+) channels and thus modulated electrical excitability of the heart and ischemia/reperfusion associated cardiac arrhythmia ( Feng et al, 2012 ).…”
Section: Discussionmentioning
confidence: 99%
“…EGF–receptor transactivation and dysregulation is involved in myocardial hypertrophy and contraction ( Eguchi et al, 2013 ; Xu et al, 2014 ). In an animal model, EGF–receptor phosphorylation led to tyrosine phosphorylation of cardiac Na(+) and L-type Ca(2+) channels and thus modulated electrical excitability of the heart and ischemia/reperfusion associated cardiac arrhythmia ( Feng et al, 2012 ).…”
Section: Discussionmentioning
confidence: 99%
“…In this study, the reciprocal expression of several catabolic genes was also validated by qPCR ( Table 1 ). Genes involved in FoxO signaling and focal adhesion pathways, such as FoxO1 [ 76 ], caveolin 1 [ 77 ], FYN proto-oncogene [ 78 ], and epidermal growth factor receptor [ 79 ], negatively regulate muscle hypertrophy.…”
Section: Resultsmentioning
confidence: 99%